Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SELARL du Dr Jacques Buvat, also known as the Centre d'Étude et de Traitement de la Pathologie de l'Appareil Reproducteur et de la Psychosomatique (CETPARP), is a specialized clinical research center and private medical practice based in Lille, France. Founded and directed by Dr. Jacques Buvat, a world-renowned expert in sexual medicine and andrology, the center focuses on the study and treatment of reproductive pathology and psychosomatic disorders. It has served as a key clinical trial site and sponsor for numerous studies involving treatments for erectile dysfunction, premature ejaculation, and male hypogonadism. The center collaborates frequently with major pharmaceutical companies such as Eli Lilly, Bayer, and Janssen-Cilag to evaluate therapies like tadalafil, testosterone, and dapoxetine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr Jacques Buvat.